Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome.
During the years 1991-1994, 97 anovulatory infertile women with polycystic ovarian syndrome (PCOS) were treated with laparoscopic electrocautery of the ovarian surface after they had failed to ovulate under ovarian stimulation. To assess the endocrinological and clinical outcome and in an attempt to determine the mechanism of action, the serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), androstenedione, testosterone and dehydroepiandrosterone sulfate (DHEAS) were determined before and after laparoscopic ovarian cautery. Fifty regularly cycling women undergoing laparoscopy for investigation of infertility or tubal ligation served as controls. In patients with PCOS but not in controls, the reduction of androgen levels and normalization of cycle length were highly significant. In contrast, LH and FSH levels rose during the first 2 days after the operation. These results resemble those reported after ovarian wedge resection. Ovulation was obtained in 90% (81 of 90) and pregnancy in 81.1% (73 of 90) of the patients; that increased to 84.4%, including the non-responders (nine patients) treated with clomiphene citrate (CC), after electrocautery. The response to ovarian electrocautery was influenced by body weight, with an ovulation rate of 95-96% in the slim and moderately obese women, decreasing to 81-82% in the really obese ones. When ovulation was established, the pregnancy rate was independent of body weight. However, a striking relationship was detected between smoking habits and pregnancy rate subsequent to ovarian electrocautery, ranging from 24% in smokers to 92% in non-smoking couples. In 30 second-look operations, de novo adhesions were found in 23.3% of the patients (7 of 30). Therefore, ovarian electrocautery is an effective procedure to improve the intraovarian mechanism of selecting a dominant follicle for patients with PCOS in whom initial medical management fails, and it appears to be one of the possible treatments for this disease. A possible postoperative complication may be adhesion formation that seem to be lower than after ovarian wedge resection.
Liguori
G
G
Department of Obstetrics and Gynecology, School of Medicine, University Federico II, Naples, Italy.
Tolino
A
A
Moccia
G
G
Scognamiglio
G
G
Nappi
C
C
D000328:Adult; D000735:Androstenedione / Q000097:blood / Q000378:metabolism; D000737:Androstenols / Q000097:blood* / Q000378:metabolism; D001835:Body Weight; D015331:Cohort Studies; D003687:Dehydroepiandrosterone / Q000097:blood / Q000378:metabolism; D004564:Electrocoagulation / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000378:metabolism; D006801:Humans; D007247:Infertility, Female / Q000601:surgery*; D010535:Laparoscopy; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism; D009994:Osmolar Concentration; D010053:Ovary / Q000601:surgery*; D010060:Ovulation / Q000502:physiology; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000503:physiopathology / Q000601:surgery*; D011183:Postoperative Complications; D011247:Pregnancy; D018873:Pregnancy Rate; D011446:Prospective Studies; D012086:Reoperation; D013739:Testosterone / Q000097:blood / Q000378:metabolism; D013997:Time Factors; D000267:Tissue Adhesions / Q000209:etiology; D016896:Treatment Outcome
D000737:Androstenols; D013739:Testosterone; D000735:Androstenedione; D003687:Dehydroepiandrosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone